CN111971029A - 含有交联的离子交换树脂的药物组合物 - Google Patents
含有交联的离子交换树脂的药物组合物 Download PDFInfo
- Publication number
- CN111971029A CN111971029A CN201880087768.3A CN201880087768A CN111971029A CN 111971029 A CN111971029 A CN 111971029A CN 201880087768 A CN201880087768 A CN 201880087768A CN 111971029 A CN111971029 A CN 111971029A
- Authority
- CN
- China
- Prior art keywords
- ion exchange
- exchange resin
- weight
- drug
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
<u>树脂酸盐编号</u> | <u>树脂</u> | <u>wt%DVB</u> | <u>尺寸(μm)</u> | <u>负载量(mg/mg)</u> |
1 | 树脂-1 | 6.8 | 63至106 | 0.243 |
2 | 树脂-1 | 6.8 | 106至150 | 0.244 |
3 | 树脂-2 | 10 | 63至106 | 0.243 |
4 | 树脂-2 | 10 | 106至150 | 0.243 |
5 | 树脂-3 | 15 | 63至106 | 0.160 |
6 | 树脂-3 | 15 | 106至150 | 0.134 |
Claims (9)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762609696P | 2017-12-22 | 2017-12-22 | |
US62/609696 | 2017-12-22 | ||
US201862637431P | 2018-03-02 | 2018-03-02 | |
US62/637431 | 2018-03-02 | ||
PCT/US2018/066506 WO2019126325A1 (en) | 2017-12-22 | 2018-12-19 | Pharmaceutical composition containing crosslinked ion exchange resin |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111971029A true CN111971029A (zh) | 2020-11-20 |
Family
ID=65024063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201880087768.3A Pending CN111971029A (zh) | 2017-12-22 | 2018-12-19 | 含有交联的离子交换树脂的药物组合物 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20210085605A1 (zh) |
EP (1) | EP3727340A1 (zh) |
KR (1) | KR20200106503A (zh) |
CN (1) | CN111971029A (zh) |
CA (1) | CA3086667A1 (zh) |
WO (1) | WO2019126325A1 (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0367746A2 (en) * | 1988-11-02 | 1990-05-09 | Richardson-Vicks, Inc. | Sustained release drug-resin complexes |
US20050265955A1 (en) * | 2004-05-28 | 2005-12-01 | Mallinckrodt Inc. | Sustained release preparations |
US20060115529A1 (en) * | 2003-05-07 | 2006-06-01 | Seonghoon Jeong | Fast-melting tablets having taste-masking and sustained release properties |
CN1845722A (zh) * | 2003-09-03 | 2006-10-11 | 马林克罗特公司 | 粒状缓释制剂及其生产 |
CN101982200A (zh) * | 2010-10-28 | 2011-03-02 | 中国中医科学院广安门医院 | 黄连总生物碱树脂复合物及其缓释制剂与它们的制备方法 |
US20130071476A1 (en) * | 2011-08-19 | 2013-03-21 | Subraman Rao Cherukuri | Rapid Melt Controlled Release Taste-Masked Compositions |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA656643A (en) * | 1963-01-29 | Wallace And Tiernan Inc. | Pharmaceutical preparation containing resin narcotic compound | |
US8343546B2 (en) | 2005-09-13 | 2013-01-01 | Coating Place, Inc. | Ion exchange resin treated to control swelling |
-
2018
- 2018-12-19 EP EP18834178.8A patent/EP3727340A1/en active Pending
- 2018-12-19 WO PCT/US2018/066506 patent/WO2019126325A1/en unknown
- 2018-12-19 CA CA3086667A patent/CA3086667A1/en active Pending
- 2018-12-19 US US16/954,376 patent/US20210085605A1/en not_active Abandoned
- 2018-12-19 KR KR1020207020793A patent/KR20200106503A/ko active Search and Examination
- 2018-12-19 CN CN201880087768.3A patent/CN111971029A/zh active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0367746A2 (en) * | 1988-11-02 | 1990-05-09 | Richardson-Vicks, Inc. | Sustained release drug-resin complexes |
US20060115529A1 (en) * | 2003-05-07 | 2006-06-01 | Seonghoon Jeong | Fast-melting tablets having taste-masking and sustained release properties |
CN1845722A (zh) * | 2003-09-03 | 2006-10-11 | 马林克罗特公司 | 粒状缓释制剂及其生产 |
US20050265955A1 (en) * | 2004-05-28 | 2005-12-01 | Mallinckrodt Inc. | Sustained release preparations |
CN101982200A (zh) * | 2010-10-28 | 2011-03-02 | 中国中医科学院广安门医院 | 黄连总生物碱树脂复合物及其缓释制剂与它们的制备方法 |
US20130071476A1 (en) * | 2011-08-19 | 2013-03-21 | Subraman Rao Cherukuri | Rapid Melt Controlled Release Taste-Masked Compositions |
Non-Patent Citations (2)
Title |
---|
FELIX GUT ET AL.: "Cation exchange resins as pharmaceutical carriers for methylene blue: binding and release", 《EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS》 * |
梁超峰等: "离子交换树脂在给药系统中的应用研究进展", 《今日药学》 * |
Also Published As
Publication number | Publication date |
---|---|
US20210085605A1 (en) | 2021-03-25 |
CA3086667A1 (en) | 2019-06-27 |
WO2019126325A1 (en) | 2019-06-27 |
EP3727340A1 (en) | 2020-10-28 |
KR20200106503A (ko) | 2020-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2256442C2 (ru) | Потребляемая пленка, предназначенная для держания во рту, и способ получения потребляемой пленки | |
US6001392A (en) | Antitussive drugs delivered by ion exchange resins | |
KR950015054B1 (ko) | 서방성 제제 및 그의 제조방법 | |
US4539199A (en) | Sustained release pharmaceutical compositions | |
JP2002534374A (ja) | 多粒子経口用量形態 | |
RU2501569C2 (ru) | Фармацевтическая композиция, содержащая алкалоиды, резистентная к рекреационным злоупотреблениям (варианты), и способ ее получения, способ приема фармацевтической субстанции, содержащей алкалоиды, теплокровным существом, добавка для предотвращения рекреационных злоупотреблений фармацевтической субстанцией, содержащей алкалоиды, и способ ее получения | |
AU2005215108B2 (en) | Pharmaceutical composition for oral application and method for preparing thereof | |
JP2002524534A (ja) | 非合法使用に適さない交感神経刺激性アミン塩を含んでなる組成物 | |
KR20170016955A (ko) | 트레프로스티닐 제제 | |
EP1898913A1 (en) | Multiple active drug-resin conjugate | |
CA2799942C (en) | Pharmaceutical composition containing solifenacin | |
CN111971029A (zh) | 含有交联的离子交换树脂的药物组合物 | |
CN111989091A (zh) | 含有树脂颗粒的药物组合物 | |
US11602507B2 (en) | Extended release oral composition of memantine or its salt and its process for the preparation | |
Kaushik et al. | Ion exchange resin complexation technique for pharmaceutical taste masking: An overview | |
Mahore et al. | Formulation and in-vitro evaluation of taste masked orodispersible tablet of metoclopramide hydrochloride | |
EP1200088A2 (en) | Paracetamol and drotaverine containing composition | |
Jadhav et al. | Ion exchange resins: a novel way to solve formulation problems | |
CN111629758A (zh) | 药物树脂化物组合物及其制备和使用方法 | |
JPH09157158A (ja) | 生薬配合製剤 | |
Bhoyar et al. | Formulation and Evaluation of Taste Masked Sustained Release Dosage Form of Metformin Hydrochloride Using Indion Resin | |
KR20210008705A (ko) | 몬테루카스트 또는 이의 약학적으로 허용가능한 염을 포함하는 액상 시럽제제 및 이의 제조방법 | |
CN115260355A (zh) | 一种阴离子交换树脂、其制备方法、该树脂与药物的复合物和其掩味制剂 | |
CN106265666A (zh) | 提高难溶性药物氯雷他定释放度的组合物及其制备方法和应用 | |
Liang et al. | Novel Sustained Release Azithromycin Resinate Fabricated by One-Pot Ion-Exchange Performed in Hydro-Alcoholic Solution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: Pennsylvania, America Applicant after: DDP special electronic materials USA Co.,Ltd. Applicant after: DDP special electronic materials eighth Co.,Ltd. Address before: Pennsylvania, America Applicant before: DDP special electronic materials American Co. Applicant before: DDP special electronic materials eighth Co.,Ltd. |
|
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: Delaware Applicant after: DDP special electronic materials USA Co.,Ltd. Applicant after: DDP special electronic materials eighth Co.,Ltd. Address before: Pennsylvania, America Applicant before: DDP special electronic materials USA Co.,Ltd. Applicant before: DDP special electronic materials eighth Co.,Ltd. |